SCHEMBL22927341

SCHEMBL22927341

c1ccc(-c2nc3ccccc3nc2-n2c3ccccc3c3c4cccc5c4c(cc32)-c2ccccc2-c2ccccc2-5)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
HPGD P15428 3/20 0.39
CASP1 P29466 2/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39
HRH4 Q9H3N8 1/20 0.38
CYP1A2 P05177 1/20 0.37
KDM4E B2RXH2 6/20 0.36
GAA P10253 3/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
POLB P06746 1/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
PDE10A Q9Y233 1/20 0.33
PKM P14618 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22927394 0.92 HSD17B10 (0.33) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL24037046 0.88 HSD17B10 (0.41) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL21366646 0.85 HSD17B10 (0.37) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL22825000 0.84 ALDH1A1 (0.50) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL22927334 0.84 HSD17B10 (0.36) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL22927358 0.84 HSD17B10 (0.36) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL22927338 0.83 ALDH1A1 (0.46) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL22824964 0.81 CASP1 (0.32) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL19655101 0.81 HSD17B10 (0.46) ALDH1A1HSD17B10L3MBTL1HPGDCASP1
SCHEMBL22927319 0.81 L3MBTL1 (0.37) ALDH1A1HSD17B10L3MBTL1HPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024466-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024466-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ICOSLG, SOD1, OR10J3 ALDH1A1 852/4885HSD17B10 2926/4885L3MBTL1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.